Cleared Traditional

K896896 - KAWASUMI SMALL VEIN INFUSION SET

K896896 is an FDA 510(k) clearance for KAWASUMI SMALL VEIN INFUSION SET, manufactured by Kawasumi Laboratories Co., Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 278-day FDA review.

K896896 · Kawasumi Laboratories Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1990
Decision
278d
Days
Class 2
Risk

K896896 is an FDA 510(k) clearance for the KAWASUMI SMALL VEIN INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Kawasumi Laboratories Co., Ltd. (Gardena, US). The FDA issued a Cleared decision on September 12, 1990 after a review of 278 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Kawasumi Laboratories Co., Ltd. devices

FDA 510(k) Submission Details - K896896

510(k) Number K896896 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 08, 1989
Decision Date September 12, 1990
Days to Decision 278 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 129d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 785
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K896896.
KAWASUMI I.V. ADMINISTRATION SET WITH BURETTE
K896893 · Kawasumi Laboratories Co., Ltd. · Sep 1990
KAWASUMI BLOOD ADMINISTRATION SET
K896894 · Kawasumi Laboratories Co., Ltd. · Sep 1990
KAWASUMI I.V. ADMINISTRATION SET
K896895 · Kawasumi Laboratories Co., Ltd. · Sep 1990
WINGED INFUSION SET
K902166 · Therex Corp. · Aug 1990
EXEL HUBER INFUSION SET
K895770 · Exel Intl. · Jul 1990
IN-LINE VIAL CONNECTION SITE
K900909 · Baxter Healthcare Corp · May 1990